NI
72
-5
DOW
23
-3
DHI
23
-2
TSN
42
-2
JNJ
57
-2
PLD
32
-9
TAP
41
-2
ZBH
53
2
WBA
38
-3
MLM
50
-14
CMG
43
-5
CCL
72
-6
VMC
75
-3
MO
57
-2
HES
36
-2
HCA
70
-5
CAT
48
-3
REGN
46
-4
WDC
61
-5
HPE
66
-5
NI
72
-5
DOW
23
-3
DHI
23
-2
TSN
42
-2
JNJ
57
-2
PLD
32
-9
TAP
41
-2
ZBH
53
2
WBA
38
-3
MLM
50
-14
CMG
43
-5
CCL
72
-6
VMC
75
-3
MO
57
-2
HES
36
-2
HCA
70
-5
CAT
48
-3
REGN
46
-4
WDC
61
-5
HPE
66
-5
Financhill
Back

PROCEPT BioRobotics 10K Form

Sell
40

PRCT
PROCEPT BioRobotics

Last Price:
$57.69
Seasonality Move:
9.14%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive PRCT News And Ratings

See the #1 stock for the next 7 days that we like better than PRCT

PRCT Financial Statistics

Sales & Book Value

Annual Sales: $224.5M
Cash Flow: $-18.8M
Price / Cash Flow: 0
Annual Sales: $7.04
Price / Book: 8.05

Profitability

EPS (TTM): -1.70000
Net Income (TTM): $-90.2M
Gross Margin: $137.1M
Return on Equity: -29.12%
Return on Assets: -20.64%

PROCEPT BioRobotics Earnings Forecast

Key PROCEPT BioRobotics Financial Ratios

  • The Gross Profit Margin over the past 6 years for PRCT is 61.07%.
  • The Selling, General & Administrative Expenses for PRCT have been equal to 76.35% of Gross Profit Margin.
  • The Research & Development expenses have been 27.75% of Revenue.
  • The Net Earning history of PRCT is -40.72% of Total Revenues.
  • Per Share Earnings over the last 6 years have been positive in 2 years.

PROCEPT BioRobotics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Health Care Equipment & Supplies
Sector: Health Care
Current Symbol: PRCT
Website: procept-biorobotics.com

Debt

Debt-to-Equity Ratio: 0.14
Current Ratio: 8.95
Quick Ratio: 7.6

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

PRCT Technical Analysis vs Fundamental Analysis

Sell
40
PROCEPT BioRobotics (PRCT) is a Sell

Is PROCEPT BioRobotics a Buy or a Sell?